1. Home
  2. ERH vs NTHI Comparison

ERH vs NTHI Comparison

Compare ERH & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Utilities and High Income Fund

ERH

Allspring Utilities and High Income Fund

N/A

Current Price

$10.21

Market Cap

90.5M

Sector

Finance

ML Signal

N/A

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$3.06

Market Cap

106.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERH
NTHI
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
106.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ERH
NTHI
Price
$10.21
$3.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
21.1K
★ 177.7K
Earning Date
01-01-0001
11-13-2026
Dividend Yield
★ 8.85%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.16
$2.96
52 Week High
$13.07
$12.99

Technical Indicators

Market Signals
Indicator
ERH
NTHI
Relative Strength Index (RSI) 31.68 43.54
Support Level N/A $3.03
Resistance Level $11.69 $3.70
Average True Range (ATR) 0.15 0.34
MACD -0.02 0.00
Stochastic Oscillator 22.02 36.84

Price Performance

Historical Comparison
ERH
NTHI

About ERH Allspring Utilities and High Income Fund

Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: